Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French STEM Today.
Press releases published on June 12, 2025

FlyHouse Appoints Aviation Finance Powerhouse John Thomas, Jr. as Chief Financial Officer
Leadership move strengthens FlyHouse’s executive team amid rapid scale and market momentum. SCOTTSDALE, AZ, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- John Thomas, Jr., a veteran finance leader with more than 25 years of experience in global …

QuadriSpace Unveils Document3D 2025: Revolutionizing 3D Documentation and Illustration
Document3D 2025 includes SolidWorks and Creo import, repackaged into product subscription tiers. ALLEN, TX, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- QuadriSpace, a pioneer in 3D communication software based in Allen, TX, is excited to announce …

ClearML Integrates NVIDIA NIM to Streamline, Secure, and Scale High-Performance AI Model Deployment
Seamless deployment of NVIDIA-optimized AI inference containers now available through ClearML’s end-to-end AI infrastructure platform SAN FRANCISCO, CA, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- ClearML, the leading end-to-end solution for …

AIPLUX Selected as Top 12 AI Tech Trail Startup at VivaTech 2025
Recognized for its secure, on-premises AI solution powered by NVIDIA GPUs, AIPLUX ensures data privacy and compliance for knowledge professionals. PARIS, FRANCE, June 12, 2025 /EINPresswire.com/ -- AIPLUX is excited to announce its selection as one of …

DBV Technologies participera au prochain congrès EAACI 2025
Châtillon, France, le 12 juin (22:30 CEST) 2025 DBV Technologies participera au prochain congrès EAACI 2025 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT ; CUSIP : 23306J309), une société biopharmaceutique en phase …

DBV Technologies to Participate in Upcoming EAACI Congress 2025
Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today …